•  
  •  
  •  
  •  

2025-10-01 06:45:43

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Reliance Infrastructure Ltd clarifies on media reports related to ED survey under FEMA
  • Sri Lotus Developers & Realty Ltd launches two new projects
  • Tamilnad Mercantile Bank join Hands with Wegofin for Payment Aggregator Business
  • Waaree Energies Ltd commences Commercial Production of 950 MW Solar Module Line Manufacturing facility
  • Bizotic Commercial Ltd receives orders worth Rs. 72.25 crores

Keywords Selected:  USA

Stock Report

  • Optiemus Infracom and Ordinary Theory USA announce JV to Manufacture & Market 'Made in India' Smart Enterprise Hardware & Industrial Solutions
  • Waaree Energies' Continued Commitment to U.S. Manufacturing and Regulatory Compliance
  • Hexaware Technologies Ltd - Update on U.S. H1B Visa Regulation Changes
  • Sasken Confirms No Business Impact from Recent U.S. H-1B Visa Program Changes
  • Puravankara brings exclusive property shows to the USA for NRIs in September 2025
  • Glenmark Pharmaceuticals Inc., USA to launch Micafungin for Injection USP, 50 mg/vial and 100 mg/vial
  • Senores Pharmaceuticals acquires ANDA for Topiramate HCl 25, 50, 100 and 200 mg tablets
  • Glenmark Pharmaceuticals Inc., USA to launch Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets
  • Bliss GVS Pharma Ltd's partner gets final approval from USFDA for Mesalamine Suppositories 1000 mg
  • SPML Infra Powers into India's Next Big Energy Revolution with Grid-Scale BESS Rollout in Exclusive Collaboration with Energy Vault
  • Glenmark Pharmaceuticals Inc., USA launches Vancomycin Hydrochloride for Injection USP, 750 mg/vial, 1.25 g/vial and 1.5 g/vial (Single-Dose Vial)
  • Polyplex USA LLC commissions trial runs of two projects
  • Welspun Corp Limited receives new orders of approx. Rs. 2400 crores
  • Glenmark Therapeutics Inc., USA launches Polyethylene Glycol 3350, Powder for Solution, 17 grams/capful - OTC
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) Multiple-Dose Vial
  • Goldiam International Ltd evaluating setting up of manufacturing facility in the USA
  • Infosys Foundation USA empowers Indiana Schools with Engineering, Robotics, and Coding STEM Skills
  • LTIMindtree announces Partnership and Strategic Investment in Voicing.AI
  • Vantage Knowledge Academy Ltd announces collaboration for delivering USA-Based Professional Courses
  • Welspun Corp Limited receives two large orders in USA
  • JSW Steel (USA) Inc. achieves Better Plants Challenge Energy Savings Goal
  • Carborundum Universal Ltd to acquire 100% stake in Silicon Carbide Products, Inc
  • Goldiam International Limited receives orders of Rs. 70 crores
  • Infosys Foundation USA opens Tech Innovation Lab in North Carolina

Latest Post

  • Reliance Infrastructure Ltd clarifies on media reports related to ED survey under FEMA
  • Sri Lotus Developers & Realty Ltd launches two new projects
  • Tamilnad Mercantile Bank join Hands with Wegofin for Payment Aggregator Business
  • Waaree Energies Ltd commences Commercial Production of 950 MW Solar Module Line Manufacturing facility
  • Bizotic Commercial Ltd receives orders worth Rs. 72.25 crores


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024